200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 550-24-3

550-24-3

550-24-3 | Embelin

CAS No: 550-24-3 Catalog No: AG003FYN MDL No:MFCD00016369

Product Description

Catalog Number:
AG003FYN
Chemical Name:
Embelin
CAS Number:
550-24-3
Molecular Formula:
C17H26O4
Molecular Weight:
294.3859
MDL Number:
MFCD00016369
IUPAC Name:
2,5-dihydroxy-3-undecylcyclohexa-2,5-diene-1,4-dione
InChI:
InChI=1S/C17H26O4/c1-2-3-4-5-6-7-8-9-10-11-13-16(20)14(18)12-15(19)17(13)21/h12,18,21H,2-11H2,1H3
InChI Key:
IRSFLDGTOHBADP-UHFFFAOYSA-N
SMILES:
CCCCCCCCCCCC1=C(O)C(=O)C=C(C1=O)O
EC Number:
208-979-8
UNII:
SHC6U8F5ER
NSC Number:
91874

Properties

Complexity:
432  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
294.183g/mol
Formal Charge:
0
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
294.391g/mol
Monoisotopic Mass:
294.183g/mol
Rotatable Bond Count:
10  
Topological Polar Surface Area:
74.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5.4  

Literature

Title Journal
XIAP inhibitor embelin induces autophagic and apoptotic cell death in human oral squamous cell carcinoma cells. Environmental toxicology 20171101
Discovery of novel second mitochondria-derived activator of caspase mimetics as selective inhibitor of apoptosis protein inhibitors. The Journal of pharmacology and experimental therapeutics 20140501
Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways. PloS one 20140101
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry 20121115
Antioxidant activity and protection of pancreatic β-cells by embelin in streptozotocin-induced diabetes. Journal of diabetes 20120901
Combination therapy of antiandrogen and XIAP inhibitor for treating advanced prostate cancer. Pharmaceutical research 20120801
Inhibition of UVB-induced oxidative damage and apoptotic biochemical changes in human lymphocytes by 2,5-dihydroxy-3-undecyl-1,4-benzoquinone (embelin). International journal of radiation biology 20120801
PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel. Bioconjugate chemistry 20120718
XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells. Molecular cancer therapeutics 20120701
Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma. The American journal of pathology 20120501
Preventive effect of embelin from embelia ribes on lipid metabolism and oxidative stress in high-fat diet-induced obesity in rats. Planta medica 20120501
Inhibition of X-linked inhibitor of apoptosis with embelin differentially affects male versus female behavioral outcome following neonatal hypoxia-ischemia in rats. Developmental neuroscience 20120301
Embelin induces apoptosis through down-regulation of XIAP in human leukemia cells. Medical oncology (Northwood, London, England) 20111201
Protective effect of embelin from Embelia ribes Burm. against transient global ischemia-induced brain damage in rats. Neurotoxicity research 20111101
Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN. Cancer letters 20110901
Embelin reduces cutaneous TNF-α level and ameliorates skin edema in acute and chronic model of skin inflammation in mice. European journal of pharmacology 20110715
Embelin ameliorates dextran sodium sulfate-induced colitis in mice. International immunopharmacology 20110601
RP-HPLC-DAD method for the estimation of embelin as marker in Embelia ribes and its polyherbal formulations. Biomedical chromatography : BMC 20110501
Protective effect of embelin against acetic acid induced ulcerative colitis in rats. European journal of pharmacology 20110301
Anticonvulsant activity of embelin isolated from Embelia ribes. Phytomedicine : international journal of phytotherapy and phytopharmacology 20110115
Synthesis and evaluation of analgesic and anti-inflammatory activities of most active free radical scavenging derivatives of embelin-A structure-activity relationship. Chemical & pharmaceutical bulletin 20110101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Synthesis and characterization of amphiphilic lipopolymers for micellar drug delivery. Biomacromolecules 20101011
Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling. The Journal of pathology 20101001
Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway. Molecular cancer research : MCR 20101001
Activation of endothelial nitric oxide synthase by the pro-apoptotic drug embelin: Striking discrepancy between nitric oxide-mediated cyclic GMP accumulation and L-citrulline formation. Nitric oxide : biology and chemistry 20100515
X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor. Molecular cancer therapeutics 20100501
Lysosomal destabilization and cathepsin B contributes for cytochrome c release and caspase activation in embelin-induced apoptosis. Molecular carcinogenesis 20100401
XIAP-mediated protection of H460 lung cancer cells against cisplatin. European journal of pharmacology 20100210
Chemopreventive and hepatoprotective effects of embelin on N-nitrosodiethylamine and carbon tetrachloride induced preneoplasia and toxicity in rat liver. Asian Pacific journal of cancer prevention : APJCP 20100101
The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP. Neurochemistry international 20091101
Effects of embelin on lipid peroxidation and free radical scavenging activity against liver damage in rats. Basic & clinical pharmacology & toxicology 20091001
Micellar delivery of bicalutamide and embelin for treating prostate cancer. Pharmaceutical research 20090901
Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer research 20090601
Inhibitory effects of antrodins A-E from Antrodia cinnamomea and their metabolites on hepatitis C virus protease. Phytotherapy research : PTR 20090401
Triterpenes from Cynomorium songaricium--analysis of HCV protease inhibitory activity, quantification, and content change under the influence of heating. Journal of natural medicines 20090101
Cell-penetrating peptide-conjugated XIAP-inhibitory cyclic hexapeptides enter into Jurkat cells and inhibit cell proliferation. The FEBS journal 20081201
Activity of 1,4-benzoquinones against formosan subterranean termites (Coptotermes formosanus). Journal of agricultural and food chemistry 20080611
Protein-protein recognition as a first step towards the inhibition of XIAP and Survivin anti-apoptotic proteins. Journal of molecular recognition : JMR 20080101
Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells. The Journal of surgical research 20071001
Free radical scavenging reactions and antioxidant activity of embelin: biochemical and pulse radiolytic studies. Chemico-biological interactions 20070425
Wound healing activity of embelin isolated from the ethanol extract of leaves of Embelia ribes Burm. Journal of ethnopharmacology 20070212
Microwave-assisted extraction of embelin from Embelia ribes. Biotechnology letters 20070201
Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products. Molecular pharmacology 20070101
Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein. Bioorganic & medicinal chemistry letters 20061115
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. Journal of molecular graphics & modelling 20061101
A nitrogen-containing 3-alkyl-1,4-benzoquinone and a gomphilactone derivative from Embelia ribes. Journal of natural products 20061101
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Effects of administration of Embelin and Curcumin on lipid peroxidation, hepatic glutathione antioxidant defense and hematopoietic system during N-nitrosodiethylamine/Phenobarbital-induced hepatocarcinogenesis in Wistar rats. Molecular and cellular biochemistry 20060301
Cell death in pancreatitis: caspases protect from necrotizing pancreatitis. The Journal of biological chemistry 20060210
Embelin derivatives and their anticancer activity through microtubule disassembly. Planta medica 20051001
Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Fitoterapia 20050901
Cytotoxic activity of embelin from Lysimachia punctata. Fitoterapia 20050601
Anti-fertility effects of embelin in female Sprague-Dawley rats may be due to suppression of ovarian function. Acta biologica Hungarica 20050101
Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. Journal of medicinal chemistry 20040506
Bioactive alkyl phenols and embelin from Oxalis erythrorhiza. Journal of ethnopharmacology 20031001
Electrochemically synthesized polymer of the plant substance embelin (2,5-dihydroxy-3-undecyl-1,4-benzoquinone). Applied biochemistry and biotechnology 20010101
Inhibitory effects of sudanese medicinal plant extracts on hepatitis C virus (HCV) protease. Phytotherapy research : PTR 20001101
Steroid hormone activity of flavonoids and related compounds. Breast cancer research and treatment 20000701

Related Products

© 2019 Angene International Limited. All rights Reserved.